tiprankstipranks
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market
MAZE
Maze Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see MAZE full AI Analyst Report?

Maze Therapeutics, Inc. (MAZE) Income Statement

90 Followers

Maze Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Maze Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Maze Therapeutics, Inc.'s net income was $-34.57M. See Maze Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22
Total Revenue
$ 0.00$ 167.50M$ 0.00$ 0.00
Gross Profit
$ -2.40M$ 167.50M$ 0.00$ 0.00
Operating Expenses
$ 140.50M$ 109.91M$ 98.55M$ 111.03M
Depreciation and Amortization
$ 2.40M$ 3.30M$ 4.09M$ 3.82M
EBITDA
$ -140.50M$ 60.88M$ -94.46M$ -107.21M
Operating Income
$ -142.90M$ 57.59M$ -98.55M$ -111.03M
Other Income/Expenses
$ 11.78M$ -4.18M$ -1.86M$ -3.91M
Pretax Income
$ -131.12M$ 53.40M$ -100.42M$ -114.94M
Net Income
$ -131.12M$ 52.23M$ -100.42M$ -114.94M
Per Share Metrics
Basic EPS
$ -3.05$ 0.08$ -2.29$ -2.63
Diluted EPS
$ -3.05$ 0.08$ -2.29$ -2.63
Weighted Average Shares Outstanding
 42.98M 43.80M 43.78M 43.78M
Weighted Average Shares Outstanding (Diluted)
 42.98M 43.80M 43.78M 43.78M
Currency in USD

Maze Therapeutics, Inc. Earnings and Revenue History